Lurbinectedin, also known as PM01183, is a synthetic tetrahydropyrrolo [4, 3, 2-de]quinolin-8(1H)-one alkaloid analogue with potential antineoplastic activity. DNA minor groove-binding agent PM01183 covalently binds to residues lying in the minor groove of DNA, which may result in delayed progression through S phase, cell cycle arrest in the G2/M phase and cell death.
DNA Alkylator/Crosslinker Related Products:
Cisplatin; Oxaliplatin; Temozolomide; Streptozocin; cyclophosphamide hydrate; Carmustine; Pepstatin A; Carboplatin